PURPOSE: Radiation-induced inflammation and production of reactive oxygen species (ROS) play a critical role in normal tissue response. In this study we have examined some aspects of these effects in lung and skin. METHODS: The superoxide dismutase (SOD) catalase mimetic, EUK-207, and genistein, an isoflavone with anti-inflammatory properties, were given post-irradiation and micronuclei (MN) formation was determined in cells derived from irradiated lung and skin. Changes in breathing rate were measured using a plethysmograph following irradiation of C57Bl6 mice knocked out for tumor necrosis factor (TNF)-alpha or its receptors, TNFR1/2, or treated with endotoxin (lipopolysaccharide - LPS). RESULTS: Both EUK-207 and genistein given after irradiation caused a large reduction in MN levels observed in lung cells during 14 weeks post-irradiation but ceasing treatment resulted in a rebound in MN levels at 28 weeks post-irradiation. In contrast, treatment with EUK-207 was largely ineffective in reducing MN observed in skin cells post-irradiation. Knock-out of TNF-alpha resulted in a reduced increase in breathing rate (peak at 12 weeks post-irradiation) relative to wild-type and TNFR1/2 knock-out. Treatment with LPS 1 h post-irradiation also reduced the increase in breathing rate. CONCLUSIONS: The increase in MN in lung cells after treatment with EUK-207 or genistein was stopped suggests that continuing ROS production contributes to DNA damage in lung cells over prolonged periods. That this effect was not seen in skin suggests this mechanism is less prominent in this tissue. The reduced level of radiation pneumonitis (as monitored by breathing rate changes) in animals knocked out for TNF-alpha suggests that this cytokine plays a significant role in inducing inflammation in lung following irradiation. The similar effect observed following LPS given post-irradiation suggests the possibility that such treatment modifies the long-term cyclic inflammatory response following irradiation in lungs. Copyright Â
PURPOSE: Radiation-induced inflammation and production of reactive oxygen species (ROS) play a critical role in normal tissue response. In this study we have examined some aspects of these effects in lung and skin. METHODS: The superoxide dismutase (SOD) catalase mimetic, EUK-207, and genistein, an isoflavone with anti-inflammatory properties, were given post-irradiation and micronuclei (MN) formation was determined in cells derived from irradiated lung and skin. Changes in breathing rate were measured using a plethysmograph following irradiation of C57Bl6 mice knocked out for tumor necrosis factor (TNF)-alpha or its receptors, TNFR1/2, or treated with endotoxin (lipopolysaccharide - LPS). RESULTS: Both EUK-207 and genistein given after irradiation caused a large reduction in MN levels observed in lung cells during 14 weeks post-irradiation but ceasing treatment resulted in a rebound in MN levels at 28 weeks post-irradiation. In contrast, treatment with EUK-207 was largely ineffective in reducing MN observed in skin cells post-irradiation. Knock-out of TNF-alpha resulted in a reduced increase in breathing rate (peak at 12 weeks post-irradiation) relative to wild-type and TNFR1/2 knock-out. Treatment with LPS 1 h post-irradiation also reduced the increase in breathing rate. CONCLUSIONS: The increase in MN in lung cells after treatment with EUK-207 or genistein was stopped suggests that continuing ROS production contributes to DNA damage in lung cells over prolonged periods. That this effect was not seen in skin suggests this mechanism is less prominent in this tissue. The reduced level of radiation pneumonitis (as monitored by breathing rate changes) in animals knocked out for TNF-alpha suggests that this cytokine plays a significant role in inducing inflammation in lung following irradiation. The similar effect observed following LPS given post-irradiation suggests the possibility that such treatment modifies the long-term cyclic inflammatory response following irradiation in lungs. Copyright Â
Authors: Christian Ostrau; Johannes Hülsenbeck; Melanie Herzog; Arno Schad; Michael Torzewski; Karl J Lackner; Gerhard Fritz Journal: Radiother Oncol Date: 2009-07-15 Impact factor: 6.280
Authors: Rosalind A Rosenthal; Karl D Huffman; Leslie W Fisette; Christy A Damphousse; Wyeth B Callaway; Bernard Malfroy; Susan R Doctrow Journal: J Biol Inorg Chem Date: 2009-06-06 Impact factor: 3.358
Authors: Dirk De Ruysscher; Ans Houben; Hugo J W L Aerts; Cary Dehing; Rinus Wanders; Michel Ollers; Anne-Marie C Dingemans; Monique Hochstenbag; Liesbeth Boersma; Jacques Borger; Andre Dekker; Philippe Lambin Journal: Radiother Oncol Date: 2009-02-03 Impact factor: 6.280
Authors: Meetha Medhora; Feng Gao; Qingping Wu; Robert C Molthen; Elizabeth R Jacobs; John E Moulder; Brian L Fish Journal: Radiat Res Date: 2014-10-31 Impact factor: 2.841
Authors: Gilda G Hillman; Vinita Singh-Gupta; David J Hoogstra; Lisa Abernathy; Joseph Rakowski; Christopher K Yunker; Shoshana E Rothstein; Fazlul H Sarkar; Shirish Gadgeel; Andre A Konski; Fulvio Lonardo; Michael C Joiner Journal: Radiother Oncol Date: 2013-09-07 Impact factor: 6.280
Authors: Mihaela Ghita; Victoria Dunne; Gerard G Hanna; Kevin M Prise; Jaqueline P Williams; Karl T Butterworth Journal: Br J Radiol Date: 2019-02-13 Impact factor: 3.039
Authors: Gilda G Hillman; Vinita Singh-Gupta; Fulvio Lonardo; David J Hoogstra; Lisa M Abernathy; Christopher K Yunker; Shoshana E Rothstein; Joseph Rakowski; Fazlul H Sarkar; Shirish Gadgeel; Andre A Konski; Michael C Joiner Journal: J Thorac Oncol Date: 2013-11 Impact factor: 15.609
Authors: Ines Batinic-Haberle; Artak Tovmasyan; Emily R H Roberts; Zeljko Vujaskovic; Kam W Leong; Ivan Spasojevic Journal: Antioxid Redox Signal Date: 2013-10-01 Impact factor: 8.401
Authors: Pataje G S Prasanna; Helen B Stone; Rosemary S Wong; Jacek Capala; Eric J Bernhard; Bhadrasain Vikram; C N Coleman Journal: Transl Cancer Res Date: 2012-06 Impact factor: 1.241